chartexchange

INTS
Intensity Therapeutics, Inc. Common stock
stockNASDAQ

At CloseNov 18, 2026 1:27:05 PM EST
2.57USD-3.745%(-0.10)21,057
After-hoursNov 18, 2026 4:42:30 PM EST
2.5148USD-2.148%(-0.0552)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Westport, CT, USA
Previous Close
$2.67
Beta
1.31
52-Week High
$15.00 2025-12-12
52-Week Low
$2.53 2026-11-18
SMA 50
$3.46
SMA 200
$4.79
Avg. Vol 10D
22,263
Avg. Vol 30D
19,757
Avg. Vol 90D
23,418
Relative Vol
1.07
1.46M
5.7100%
Feb 19, 2026 · 1-for-25 (reverse)
Nov 7, 2026
Nov 6, 2026
Nov 5, 2026
INTS Profile

intensity therapeutics is a connecticut based biopharmaceutical company whose mission is to create safer and more efficacious chemotherapy treatments. intensity therapeutics is a preclinical, in vivo stage company seeking investors interested in helping to advance the company's technology and products.

INTS Performance
PeriodPriceDateChangeBeta
1W3.102026-11-12-11.94%0.494
1M3.292026-10-19-17.02%1.986
3M4.202026-08-19-35.00%1.382
6M4.592026-05-19-40.52%0.979
1Y10.692025-11-19-74.45%1.310
2Y75.002024-11-19-96.36%—
5Y149.002023-06-30-98.17%-0.097
INTS Stock Summary

Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) stock price today is $2.73, and today's volume is 21,057. INTS is up 2.247% today. The 30 day average volume is 19,757. INTS market cap is $9.01M with 3.30M shares outstanding.